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Optimal monitoring of the HIV viral load (VL) in antenatal and 
postnatal clients is key to identifying those at risk of mother-to-child 
transmission of HIV (MTCT).[1] Timeous identification of clients 
who are failing treatment will facilitate adherence and treatment 
interventions and lower MTCT risk. Globally, HIV elimination is 
aimed to be achieved by 2030, and one way to ensure good progress 
is to meet the HIV 90-90-90 targets at national level,[2] i.e. 90% of 
people living with HIV should know their status, 90% of people 
living with HIV should be on antiretroviral therapy (ART), and 90% 
of those on ART should be virally suppressed.[2] In South Africa (SA), 
the prevention of MTCT (PMTCT) antenatal care cascade manages 
to achieve >90% coverage for HIV testing and for ART initiation.[3] 
The service delivery performance of these two PMTCT indicators 
is further strengthened by periodic monitoring and evaluation 
through the national health information systems and the antenatal 
sentinel surveys.[3] Systematic tracking of the third 90 for the PMTCT 
programme in SA was only adopted in 2019.[4]
During the period 2015 - 2019, the SA PMTCT guidelines for 
monitoring VL recommended 6-monthly VL testing for mothers 
who were virally suppressed (≤1 000 copies/mL) and monthly testing 
for unsuppressed mothers.[5] The turnaround times (TATs) from 
blood draw to returning results to clients should not delay clinical 
management. Although the 2015 guidelines expected results to be 
received by clients within 2 weeks and the recent 2019 guideline 
revisions require VL-informed care to be issued within 1 week, it 
is unclear what TATs are currently achieved in the public primary 
healthcare setting.[4,5] The quality of VL care service is also important, 
as it has the potential to influence client participation and TATs. 
Quality of care, in this case, would include ensuring that all blood 
samples yield a VL result and all VL-tested mothers receive their 
results in the shortest time possible. In addition, the meaning and 
implication of the mother’s VL result need to be explained to her 
during collection of results.
Objectives
Considering the scarcity of information around the third 90 for 
antenatal and postnatal clients, we sought to understand two aspects 
of routine VL monitoring in high antenatal HIV prevalence districts 
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Background. Barriers to monitoring maternal HIV viral load (VL) and achieving 90% viral suppression during pregnancy and breastfeeding 
still need to be understood in South Africa (SA).
Objectives. To measure quality of VL care and turnaround times (TATs) for returning VL results to women enrolled in the prevention of 
mother-to-child transmission of HIV (PMTCT) programme in primary healthcare facilities.
Methods. Data were obtained from a 2018 cross-sectional evaluation of the PMTCT Option B+ programme in six SA districts with high 
antenatal and infant HIV prevalence. Quality of VL care was measured as the proportion of clients reporting that results were explained to 
them. TATs for VL results were calculated using dates abstracted from four to five randomly selected facility-based client records to report 
overall facility ‘short TAT’ (≥80% of records with TAT ≤7 days). Logistical regression and logit-based risk difference statistics were used.
Results. Achieving overall short TAT was uncommon. Only 50% of facilities in one rural district, zero in one urban metro district and 
9 - 38% in other districts had short TAT. The significant difference between districts was influenced by the duration of keeping results 
in facilities after receipt from the laboratory. Expected quality of VL care received ranged between 66% and 85%. Client-related factors 
significantly associated with low quality of care, observed in two urban districts and one rural district, included lower education, recent 
initiation of antiretroviral treatment and experiencing barriers to clinic visits. Experiencing clinic visit barriers was also negatively associated 
with short TATs.
Conclusions. We demonstrate above-average quality of care and delayed return of results to PMTCT clients. Context-specific interventions 
are needed to shorten TATs.
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of SA. Firstly, we sought to document average VL TATs achieved by 
facilities, and secondly, we implemented a simple measure of self-
reported quality of client care during receipt of VL results. We used 
client recall of the healthcare provider explaining the meaning of the 
VL results as a measure of quality, as this is critical for improving the 
client’s attitude towards healthcare uptake. Lastly, using multivariable 
analyses, we assessed facility structural factors associated with TAT, 
client-related factors associated with the self-reported quality of care, 




A cross-sectional process evaluation of PMTCT Option B+ 
implementation was conducted in six SA districts between February 
and June 2018, to assess programme performance 2 years after national 
roll-out. Study districts were selected from 25 districts with the highest 
infant HIV incidence and antenatal HIV prevalence in 2014 - 2015, 
and were: (i) a periurban district, OR Tambo in Eastern Cape Province 
(Periurban EC); (ii) two urban metros, Ekurhuleni in Gauteng Province 
(Urban GP) and eThekwini in KwaZulu-Natal Province (Urban KZN); 
(iii) two rural districts, Greater Sekhukhune in Limpopo Province 
(Rural LP) and Bojanala in North West Province (Rural NW); and 
(iv) one periurban district with a large rural setting, Ehlanzeni in 
Mpumalanga Province (Rural/periurban MP). The process evaluation 
was carried out at managerial/policymaker level (interviews), service 
delivery level (interviews with healthcare workers and assessment 
of facility registers/documentations), and user level (interviews with 
mothers). Data from facility registers and maternal interviews were 
used for this analysis.
Sample sizes were determined to estimate district-level maternal 
data for key PMTCT indicators, using an absolute precision of 
10% and a design effect of 2. Mothers of younger (4 - 14 weeks old, 
i.e. early postnatal group) and older (6 - 12 months old, i.e. mid-
postnatal group) children, representing HIV-exposed and unexposed 
children, were included to broadly represent PMTCT programme 
impact. A minimum target sample size of 120 mother-infant pairs 
was used for each of the four strata (i.e. an HIV-positive and an HIV-
negative group of mothers in each of the two postnatal stages) per 
district. In each district, 24 medium to large facilities were randomly 
selected, and an average of five mothers were targeted per stratum 
in each facility. From the above postnatal sample, HIV-positive 
mothers were interviewed for assessing quality of VL care received. 
To measure TATs for VL results, a randomly selected equal sample of 
five PMTCT client records, from facility longitudinal registers at any 
point along the PMTCT cascade, was targeted per facility.
Quality of VL care received
Quality of VL care was defined as the explanation of VL results to 
a patient during result receipt as part of routine HIV counselling 
activities. We measured it from participants’ recall of the meaning of 
their most recent VL result being explained to them (here referred to 
as ‘expected’ quality of VL care) or not explained to them (i.e. ‘low’ 
quality of VL care). Participants who reported not having collected 
their most recent VL result were included in the ‘low-quality’ group. 
In addition, we described participants’ ability to recall the actual VL 
value. All participants who ever received a VL test during or after the 
most recent pregnancy were included.
TAT of VL monitoring
Three dates were extracted (from facility registers) from each 
randomly selected PMTCT client record to calculate TAT in days 
from the date of blood draw to the date on which the client received 
her VL results: the date of blood draw (which in all cases was the 
same as the date the sample was couriered to the laboratory), the date 
the facility received hard-copy VL results from the laboratory, and 
the date the client received results. The overall TAT to client for VL 
results was calculated as the date the client received results minus the 
date of blood draw. We were also interested in further understanding 
the total laboratory TAT (the date the facility received VL results 
from the laboratory minus the date the sample was couriered to the 
laboratory) and the clinical TAT (the date the client received results 
minus the date the facility received results from the laboratory).
Statistical methods
The study was designed to present results at district level. The 
quality of VL care was analysed using individual participant data, 
and all proportions and point estimates were weighted to account for 
sample size realisation within each stratum and the sampling frame 
of facilities within each district. A χ2 test was used to describe the 
quality of VL care. A logistic regression model was used to determine 
associations between quality of VL care received and the participant’s 
sociodemographic and healthcare uptake characteristics, adjusted 
for postnatal period. Available participant sociodemographic 
information and healthcare uptake history were included together 
with socioeconomic status (SES) group. SES was calculated from 
household assets and source of income using principal component 
analyses and classified into high and low SES.
All three types of TATs for VL were presented as binary, ‘short 
TAT’ (≥80% of records with TAT ≤7 days) and ‘delayed TAT’ (<80% 
of records with TAT ≤7 days). A χ2 test was used to describe TATs 
for VL between districts and Spearman’s correlation to describe the 
relationship between total laboratory TAT and clinical TAT within 
each district. A logistic regression model was used to investigate 
the relationship between overall TAT to client and operational and 
infrastructural factors (i.e. methods used to receive VL results, use 
of any point-of-care (PoC) technology for VL care, and systems for 
tracing participants and monitoring retention in care). To determine 
whether the quality of VL care received by clients in a facility was 
related to the average overall TAT to clients observed at that facility, 
we calculated a logit-based risk difference in the quality of VL care 
received between facilities having short v. those with delayed overall 
TAT to client. The risk difference analysis was adjusted for all 
participant factors showing a significant association with quality of 
VL care received, in any district.
All analyses were performed in Stata SE14 (StataCorp, USA), and 
a 5% (p<0.05) significance level was used.
Ethical considerations and consent to participate
Ethics approval for the study was granted by the South African 
Medical Research Council Ethics Committee in 2015 (ref. no. ID- 
EC039-11/2015) and the Associate Director of Science, Center for 
Global Health at the US Centers for Disease Control and Prevention. 
All participants signed informed consent.
Results
Sample summary
We enrolled 853 HIV-positive mothers (totalling to 60% sample size 
realisation) from 132 facilities. Overall, 769 participants (90.2%) 
reported ever having a VL test since the first antenatal care visit and 
were included in the analyses for quality of VL care. As expected, 
half (50.7%) of the sample comprised the early postnatal group. 
Only 10.7% (n=82/769) of HIV-positive mothers could recall their 
actual VL.
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Ninety one percent (n=120) of the facilities 
had at least 80% of reviewed client records 
with complete dates for measuring VL TATs 
(n=16/20 in Rural NW, n=17/21 in Urban 
GP, n=22/22 in Urban KZN, n=22/22 in 
Rural/periurban MP, n=23/23 in Periurban 
EC and n=20/24 in Rural LP).
Quality of VL care received
The proportion of clients who received 
the expected quality of VL care was >65% 
in all facilities (data not shown) and in 
each postnatal group (Fig. 1). The highest 
outcomes were observed in Rural/periurban 
MP (81.6% and 85.2% for mid- and early 
postnatal groups, respectively). Rural NW 
and Urban GP followed closely (ranging 
between 77.5% and 82.4%). There was no 
significant difference in proportions between 
postnatal groups, but proportions for the 
early postnatal groups were higher in most 
districts. The majority (n=60/82) of clients 
who could recall their VL reported a VL of 
>1 000 copies/ml, and only 4/82 reported an 
undetectable VL.
The quality of VL care received was 
significantly associated with maternal age, 
education, unplanned pregnancy, timing of 
ART initiation and having experienced clinic 
visit barriers (i.e. hindrances to keeping clinic 
appointments such as lack of family support, 
transport issues and clinic waiting times 
(Table 1), in at least one of three districts 
(both urban metros and Rural LP) (Table 2). 
In Urban GP, the odds of receiving the 
expected quality of VL care was significantly 
reduced among postnatal mothers who 
had: (i) achieved primary-level education 
or less (adjusted odds ratio (aOR) 0.1; 95% 
confidence interval (CI) 0.0 - 0.7; p=0.024); 
(ii) an unplanned pregnancy (aOR 0.2; 95% 
CI 0.0 - 0.7; p=0.020); (iii) initiated ART after 
enrolling into antenatal care for the most 
recent pregnancy (i.e. recent ART initiation) 
(aOR 0.1; 95% CI 0.0 - 0.7; p=0.020); or (iv) 
experienced clinic visit barriers (aOR 0.1; 
95% CI 0.0 - 0.6; p<0.001), while mothers 
aged 25 - 34 years had a nearly 6 times odds 
of receiving the expected quality of VL care 
compared with older mothers (aOR 5.7; 95% 
CI 1.1 - 29.5; p=0.037). In the second urban 
metro, Urban KZN, the odds of receiving 
the expected quality of care was significantly 
reduced only among postnatal mothers who 
experienced clinic visit barriers (aOR 0.2; 
95% CI 0.1 - 0.9; p=0.039). The odds of 
receiving the expected quality of VL care in 
Rural LP was significantly reduced among 
postnatal mothers who had: (i) primary-level 
education or less (aOR 0.1; 95% CI 0.0 - 0.7; 
p=0.024); (ii) initiated ART after enrolling 
into antenatal care (aOR 0.2; 95% CI 0.1 - 
0.8; p=0.024); or (iii) experienced clinic visit 
barriers (aOR 0.1; 95% CI 0.0 - 0.6; p=0.011).
TAT of VL monitoring
The majority of facilities in all districts were 
supported by short total laboratory TAT, 
ranging from 50.0% in Rural LP to 86.4% 
in Rural/periurban MP (Fig. 2). Urban GP 
had 64.7% of facilities supported by short 
total laboratory TAT, and the remaining 
three districts had 72 - 75%. The χ2 p-values 
indicated uniformity in total laboratory TAT 
support across all districts. Clinical TAT 
varied widely between districts. Only two 
districts had at least half of their facilities 
achieving a short clinical TAT (Rural/
periurban MP with the highest at 63.6% and 
Rural NW with 50%). Both urban metro 
districts had the lowest proportions of 
facilities achieving an average short clinical 
TAT (13.6% of facilities in Urban KZN and 
zero facilities in Urban GP). Overall, TAT to 
client resembled clinical TAT, although only 
Rural/periurban MP had half of the facilities 
achieving the desired short overall TAT to 
client. Rural NW had 37.5% of facilities 
achieving a short overall TAT to client and 
  
Rural NW (4 - 14 wk n=56, 6 - 12 mo n=70; p=0.636)
Rural LP (4 - 14 wk n=54, 6 - 12 mo n=56; p=0.687)
Rural/periurban MP (4 - 14 wk n=65, 6 - 12 mo n=82; p=0.556)
Periurban EC (4 - 14 wk n=42, 6 - 12 mo n=64; p=0.204)
Urban KZN (4 - 14 wk n=81, 6 - 12 mo n=94; p=0.822)
Urban GP (4 - 14 wk n=58, 6 - 12 mo n=47; p=0.638)
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Fig. 1. Proportion of women with viral load results explained to them (N=769 women interviewed). 
The p-values are from a χ2 test comparing proportions between postnatal groups. Horizontal lines 
to the right of the bars represent 95% confidence intervals. (Rural NW = Bojanala District in North 
West Province; Rural LP = Greater Sekhukhune District in Limpopo Province; Rural/periurban MP = 
Ehlanzeni District in Mpumalanga Province; Periurban EC = OR Tambo District in Eastern Cape 
Province; Urban KZN = eThekwini District in KwaZulu-Natal Province; Urban GP = Ekurhuleni 
District in Gauteng Province.)
Table 1. Factors reported to affect adherence to clinic appointments among clients 
who reported facing barriers to attending scheduled clinic visits (N=519)
Factor n Weighted % out of 519
Waiting time at the clinic 268 50.6
Support from partner 79 15.6
Transport challenges 72 13.9
Support from family 66 12.8
Fear of being sick 49 10.3
Financial related 56 10.1
Stigma 35 7.1
Healthcare worker attitudes 34 5.0
Work or school attendance 12 2.8
Healthcare worker support 13 2.8
Household chores 16 2.7
No food 7 2
Peer support 7 1.5
No disclosure of HIV status 8 1.1
Disclosure of HIV status 10 1
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Rural LP had 25.0%. No facility achieved 
this in Urban GP, and only 9.1% did so in the 
other urban metro.
Clinical TAT and total laboratory TAT 
were unrelated (all p-values >0.05 for 
Spearman’s correlation, see Supplementary 
File 1, available at http://samj.org.za/public/
sup/15496.pdf).
No facility-level infrastructural and 
operational factors evaluated were signifi-
cantly associated with overall TAT to client 
(Table 3).
Relationship between quality and 
TAT of VL monitoring
The risk difference for quality of VL care 
received between short overall TAT to client 
v. delayed TAT at facility level was evaluated. 
The quality of VL care received by clients 
was not significantly associated with the 
respective facility’s average overall TAT 
to client, with adjustment for individual 
client characteristics significantly associated 
with quality of care at any district (Table 4). 
However, short overall TAT to client 
was significantly associated with the risk 
of unplanned pregnancy and not having 
experienced clinic visit barriers in Rural 
LP and Periurban EC, respectively. In Rural 
LP facilities, short overall TAT to client 
was significantly associated with a 0.28 
percentage point (adjusted risk difference 
(ARD) 0.28%; 95% CI 0.07 - 0.49; p=0.015) 
increased risk of having had an unplanned 
pregnancy. In Periurban EC facilities, short 
overall TAT to client was significantly 
associated with a 0.41 percentage point 
(ARD 0.41%; 95% CI –0.63 - 0.21; p<0.001) 
reduced risk of having experienced clinic 
visit barriers.
Discussion
Evaluation of VL monitoring service delivery 
within the PMTCT cascade is needed for 
understanding the risk of MTCT and barriers 
to achieving the third 90 of the UNAIDS 
90-90-90 goals. To contribute to fulfilling this 
need, we evaluated: (i) the quality of VL care 
received by PMTCT clients using routine 
healthcare facilities; and (ii) average TATs 
for return of VL results to PMTCT clients 
achieved by healthcare facilities, in six SA 
districts with a high maternal and infant HIV 
burden. We observed, according to client 
recall, that over two-thirds of them received 
the expected quality of care. However, <40% 
of facilities in five districts (50% in the sixth 
district) achieved optimal TATs for returning 
VL results to clients. The expected quality 
of VL care was significantly associated 
with maternal age, education, unplanned 
pregnancy, timing of ART initiation and 
experiencing clinic visit barriers. None of the 
infrastructural and operational factors linked 
to VL monitoring systems were significantly 
associated with average facility TATs. 
However, we observed that total laboratory 
TAT was consistent between districts, 
while clinical TAT varied significantly and 
influenced the significant variation observed 
for the overall TAT for VL. Overall facility 
TAT was not related to the quality of VL care 
received in the facilities, but was associated 
with unplanned pregnancy and experiencing 
clinic visit barriers.
Factors significantly associated with 
quality of VL care were observed in both 
urban metros and one rural district. Clinic 
visit barriers, low education, recent ART 
initiation and unplanned pregnancy were 
associated with not receiving the expected 
quality of care, the latter factor being 
common across all three districts. Clinic visit 
barriers cited by clients included common 
problems in similar low- to middle-income 
country settings, i.e. waiting times in the 
clinic, family/partner support, transport and 
financial-related challenges (Table 1).[6-8] A 
positive note in one periurban district was 
that facilities achieving overall short TATs 
were significantly less likely to have clients 
reporting clinic visit barriers.
The association of low educational 
qualification with poor quality of HIV care/
uptake is another persisting problem in SA.[9] 
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Fig. 2. Proportion of facilities with short TATs for viral load results. The p-values are from a χ2 test. 
Horizontal lines to the right of the bars represent 95% confidence intervals. (TAT = turnaround time; 
Total laboratory TAT = the time period including courier of blood sample to the laboratory, processing 
time in the laboratory and return of results to the facility; Clinical TAT = the time period results were 
kept in the facility after receipt from the laboratory and before client collection; Overall TAT = the sum 
of clinical TAT and total laboratory TAT; Rural NW = Bojanala District in North West Province; Rural 
LP = Greater Sekhukhune District in Limpopo Province; Rural/periurban MP = Ehlanzeni District in 
Mpumalanga Province; Periurban EC = OR Tambo District in Eastern Cape Province; Urban KZN = 
eThekwini District in KwaZulu-Natal Province; Urban GP = Ekurhuleni District in Gauteng Province; 
n = number of healthcare facilities surveyed.)
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clients are likely to feel disempowered to engage proactively with 
healthcare workers, so HIV counselling needs to be a universal 
standard procedure at every HIV-related healthcare contact. It is 
unclear why only a tenth of participants, most of whom had very 
high VLs, could recall their VL, even though more than half of 
the participants had reached high school. The reason is probably 
a combination of ill health-driven (or high VL) need to memorise 
one’s VL, healthcare worker commitment, more recent collection of 
the VL result, service delivery culture or lack of quality improvement 
initiatives.[10-12]
Recent ART initiation significantly reduced the odds of receiving 
expected care in two districts. The Option B+ policy follows a test-and-
treat strategy, so this group is likely to have been diagnosed with HIV 
recently. Related findings of poor healthcare outcomes among PMTCT 
clients with recent ART initiation have been reported across sub-
Saharan Africa, highlighting a need for early linkage to complementary 
peer or other forms of community-based support.[8,13-16] The home 
nurse programme in Tanzania and the postnatal peer-support clubs 
model currently used in some parts of SA are good examples for 
consideration nationwide.[17,18]
The association between unplanned pregnancy and undesirable 
HIV care outcomes is also not new in these settings, and interventions 
to reverse this chronic problem are overdue.[19,20] The unexpected 
positive association with short TAT in Rural LP facilities is worth 
noting, however. The majority (70%) of women reporting unplanned 
pregnancy in this district were already on ART before enrolling 
into antenatal care. The cross-sectional study design is limiting to 
understand temporality in this outcome. We could hypothesise that 
tracing high-risk clients identified during pregnancy, to reduce vertical 
HIV transmission risk, is prioritised in this district.
The WHO-recommended target for eliminating vertical HIV 
transmission to ≤50 new HIV infections per 100 000 live births 
has not been met in SA, and maintaining >90% VL suppression in 
HIV-positive mothers would reduce the risk of MTCT.[21] In order to 
meet these goals, the previous national PMTCT guidelines expected 
VL-informed HIV care to be issued within 2 weeks, while the recently 
revised guidelines (2019) recommend that the healthcare worker check 
VL results and call the client within a week from the time of blood 
draw.[4,5] The TATs we observed here question whether it is feasible to 
maintain viral suppression in >90% of PMTCT clients across the entire 
period of pregnancy and breastfeeding. Inefficient TATs in HIV care 
are still a common problem in other African settings.[11,12,22-27] Although 
fewer facilities managed to achieve desirable TATs in the present study, 
the unbiased and shorter laboratory TATs are a promising outcome 
for SA. However, the fact that a largely rural district can achieve 
better overall outcomes than urban districts, and that merely having 
PoC technologies does not guarantee overall optimal TATs, reiterates 
the complexity of achieving optimal VL monitoring processes.[11,28] 
While the urban metro, with delayed clinical and overall TATs in all its 
facilities, is concerning, the rural/periurban district presenting better 
TAT outcomes indicates that efficient systems are possible. Ongoing 
quality improvement initiatives such as that implemented in Uganda 
have potential to improve service delivery processes and should be 
adopted widely.[10,29] SA is currently piloting a digitised system called 
eLABs to track and improve VL monitoring systems and TATs.[30]
Study limitations
The sample size for the assessment of TATs was only powered to give 
average performance at facility level, and a patient-level assessment of 
whether women are being monitored for VL according to guidelines 





TAT ≤7 days, %
Unadjusted 
OR (95% CI) p-value aOR (95% CI) p-value
Main method of receiving VL results 
 SMS (text message) printer/email/online access, 
such as Tier
15 13.3 Ref.
NHLS courier 105 26.7 2.3 (0.5 - 11.1) 0.277 1.8 (0.3 -10.6) 0.533
Use of PoCT for VL
No 69 26.1 Ref.
Yes 51 23.5 0.9 (0.4 - 2.0) 0.749 1.0 (0.4 - 2.5) 0.972
Trace clients with high-risk HIV results 
Not done 9 33.3 Ref.
Phone call only 57 31.6 0.9 (0.2 - 4.1) 0.916 0.6 (0.1 - 3.7) 0.555
Counsellor/DOTs only 16 18.8 0.5 (0.1 - 3.0) 0.418 0.6 (0.1 - 5.4) 0.655
Using phone call/counsellors/DOTs 38 15.8 0.4 (0.1 - 1.9) 0.240 0.4 (0.1 - 2.6) 0.312
Has system to monitor retention in care for 1 year
No 16 25.0 Ref.
Yes 104 25.0 1.0 (0.3 - 3.4) 1.000 1.3 (0.4 - 5.1) 0.665
District
Periurban EC 23 26.1 Ref.
Urban GP 17 0.0 1
Urban KZN 22 9.1 0.3 (0.1 - 1.6) 0.152 0.4 (0.1 - 2.6) 0.332
Rural/periurban MP 22 50.0 2.8 (0.8 - 9.9) 0.103 2.9 (0.7 - 11.4) 0.137
Rural LP 20 25.0 0.9 (0.2 - 3.7) 0.935 1.1 (0.2 - 4.7) 0.939
Rural NW 16 37.5 1.7 (0.4 - 6.7) 0.449 2.0 (0.4 - 9.1) 0.367
TAT = turnaround time; OR = odds ratio; CI = confidence interval; aOR = adjusted odds ratio; NHLS = National Health Laboratory Service; PoCT = point-of-care testing;  
VL = viral load; DOTs = district outreach teams; Periurban EC = OR Tambo District in Eastern Cape Province; Urban GP = Ekurhuleni District in Gauteng Province;  
Urban KZN = eThekwini District in KwaZulu-Natal Province; Rural/periurban MP = Ehlanzeni District in Mpumalanga Province;  
Rural LP = Greater Sekhukhune District in Limpopo Province; Rural NW = Bojanala District in North West Province.
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is needed. Although hard-copy records are the main source for 
TAT information, we did not consider that sometimes facilities use 
electronic tracking systems concurrently to expedite patient care. 
The time since the recent VL test was not considered and could have 
introduced recall bias. The contribution of service provider factors to 
the quality of VL care was not assessed. The study was designed to 
report district-level outcomes for individual patient data, so pooled 
analyses could not be done to benefit from the power of a larger 
sample size. However, the study was able to show that service delivery 
performance differs between districts, mirroring the heterogenous 
prevalence of antenatal HIV and MTCT, and further emphasising 
the need for interventions tailored to address challenges at the sub-
regional contexts.[3] The cross-sectional nature of the study design 
limits our understanding of temporality, especially for associations 
between short TAT and unplanned pregnancy.
Conclusions
This study has provided preliminary findings that will help to inform 
improved programme interventions to address some bottlenecks 
to monitor the third 90 of the UNAIDS 90-90-90 goals within the 
PMTCT cascade. The total laboratory TATs in SA are promising 
and reflect the country’s efforts to leverage laboratory services 
to all settings. There is clearly a challenge in getting VL results 
back to clients from the facilities, and this appears to be more 
problematic in urban settings and contributed to by client-related 
barriers to clinic attendance. Delayed return of results to clients is 
particularly concerning during PMTCT, as rapid viral suppression 
is required to reduce the risk of transmission. The increasing use 
of mobile technology such as the MomConnect mobile service for 
promotional healthcare messaging provides an opportunity to explore 
new avenues to encourage women to collect their results timeously. [31] 
The current roll-out of the eLABs system for digitised tracking 
and improving service delivery efficiency for VL monitoring could 
improve outputs. [30] The quality of VL care was above average, but 
quality improvement initiatives need to continue. Periodic evaluation 
of the efficiency and quality of VL monitoring processes in countries 
that have not met the targets for eliminating MTCT is non-negotiable.
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